Rasi Electrodes Board of Directors

Get the latest insights into the leadership at Rasi Electrodes. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. B Ranjit Kumar Kothari Chairman
Mr. B Popatlal Kothari Managing Director
Mr. Hitesh M Dharamshi Independent Director
Mr. Ajay Goyal Independent Director
Mrs. Aashika Kumari Independent Director
Mrs. Payal Jain Independent Director
Mr. Suresh Kumar Mehta Independent Director
Ms. Kavita Patel Independent Director

Rasi Electrodes Share price

RASIELEC

18.52

0.29 (-1.54%)
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

19.24

Today's Low

18.48

52 Week Low

16.10

52 Week High

42.50

The current prices are delayed, login to your account for live prices

Rasi Electrodes FAQs

The board at Rasi Electrodes consists of experienced professionals, including Mr. B Ranjit Kumar Kothari , Mr. B Popatlal Kothari , and others, overseeing the company’s strategic and corporate governance.

Directors at Rasi Electrodes are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. B Ranjit Kumar Kothari is the current chairman at Rasi Electrodes.

Executive directors at Rasi Electrodes are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Rasi Electrodes adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Rasi Electrodes, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.